June 30, 2010

New Product Release

Regulatory
Genovis introduces a new product – Mass Spec Kit – that will be of great use in development and production of antibody-based drugs. This product is a new tool that can facilitate and give a more cost-effective quality control for antibody manufacturers.

The Product Release is published at Genovis web site: www.genovis.com

Find out more, contact: Sarah Fredriksson, CEO, Genovis AB Tel: +46 46 10 12 35 sarah.fredriksson@genovis.com

Genovis is a biotech company on the leading edge of nanotechnology and nanoparticles. The company’s patented nano-induced magnetic transfer (NIMT®) technology was developed to facilitate effective preclinical research for the life science industry. Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission is our certified adviser.

wkr0005.pdf
  • Svenska